Sexual Medicine Society of North America, Inc.

Scientific Program Abstracts

All times indicated below are in EST.

All sessions will be recorded and made available on-demand for a longer period for those who are registered.

Monday, November 9, 2020
Monday, November 9, 2020
07:00 p.m. - 09:00 p.m.
Abstract Session 1 - Mental Health, Cancer Survivorship and Epidemiology
Moderators: Rose Hartzell-Cushanick, PhD, EdS, CHES, LMFT, IF & Daniela Wittmann, PhD, MSW
#erectiledysfunction: 5-year Comprehensive Analysis of the Twitter Discussions Associated with Erectile Dysfunction (#001)
Speaker: Kassandra E. Zaila (USA)
New Cognitive Behavioral Treatment for Delayed Ejaculation Using a Masturbation Aid Device and Mobile App: A Case Study (#002)
Speaker: Jesus Eugenio Rodriguez (Spain)
Characteristics of Men Who Use Direct to Consumer Men’s Health Telemedicine Services in an Online Population (#003)
Speaker: Matthew T. Hudnall (USA)
How do the Interdisciplinary Professional Relationships Formed in the Creation of a Men's Health Program Influence Members' Work? (#004)
Speaker: Maggie Gannon (USA)
Frequency of Depression and Anxiety in Young Men with Erectile Dysfunction (#005)
Speaker: Tad Manalo (USA)
Should Men Presenting With Depression Be Screened For Low Testosterone? (#006)
Speaker: Marisa Gray (USA)
Prepubertal Masturbation Techniques Inflicting Penile Trauma and Erectile Dysfunction in Healthy Adult Males: A Call for Prevention and Early Education (#007)
Speaker: Meghan Davis (USA)
Long-term Success with Diminished Opioid Prescribing After Men's Health Urologic Procedures Using Standardized Postoperative Opioid Prescribing Guidelines: An Interrupted Time-Series Analysis (#008)
Speaker: Bridget Findlay (USA)
The Determinants of HIV-Testing Following a Sexual Assault Forensic Medical Exam (#009)
Speaker: Taylor Perry-Crawford (USA)
How Sexual Orientation Effects Sexual Health Discussions and Care with Providers: A Study Using the National Survey for Family Growth 2011-2017 (#010)
Speaker: Jenna Reich (USA)
Sexual Identity Differences in Colon Cancer Screening Practices Among US Adults (#011)
Speaker: Grace Wei (USA)
Survey of a Contemporary Cohort of Oncology Providers' Attitudes and Practices toward Sexual Health in Cancer Care (#012)
Speaker: Justin Dubin (USA)
Facing Cancer Together: A Longitudinal Study of Psychological Distress, Relationship Satisfaction, and Sexual Functioning among Rectal Cancer Patients and Their Partners (#013)
Speaker: Chiara Acquati (USA)
Demographics and Characteristics of Patients Accessing a Prostate Cancer Supportive Care Program's Sexual Rehabilitation Clinic (#014)
Speaker: Julie Wong (Canada)
Predictive Ability of Free Testosterone on Sexual Function in Prostate Cancer (#015)
Speaker: Edward Choi (USA)
Testosterone Deficiency in Men being Treated for Primary Pancreatic Cancer (#016)
Speaker: Holly K. Conger (USA)
Sexual Rehabilitation Recommendations for Prostate Cancer Survivors and Their Partners from a Bio-psycho-social Prostate Cancer Supportive Care Program (#017)
Speaker: Wallace Yuen (Canada)
Predicting Quality of Life Considerations in Prostate Cancer Discussions: Using Social Media to Identify an Andrologists Place in a Urologic Oncologist's World (#018)
Speaker: Tommy Jiang (USA)
Sexual Health Among Adolescent Young Adult Males with Cancer: An Update (#019)
Speaker: Justin Dubin (USA)
Comparing Postoperative Outcomes and Risk Factors for Patients Undergoing Partial vs Total Penectomy for Penile Carcinoma: Analysis from the National Surgical Quality Improvement Program (NSQIP) Database (#020)
Speaker: Omer Raheem, MD (USA)
Implementation and Evaluation of Sexual Health Care Training for Oncology Providers (#021)
Speaker: Maggie Gannon (USA)
07:00 p.m. - 09:00 p.m.
Abstract Session 2 - Androgens and Ejaculation/Orgasm Disorders
Moderators: Ryan P. Smith, MD & Alexander J. Tatem, MD
Assessment of Public Interest and Current Trends in Testosterone Replacement Therapy (#022)
Speaker: Wade Muncey (USA)
Evaluating the Impact of Telemedicine on Access to Male Sexual Medicine During the COVID-era (#023)
Speaker: Matthew Rabinowitz (USA)
Dual Therapy with rFSH and HCG Results in a Significantly Shorter Time to Return of Spermatogenesis than Combination HCG and Clomiphene (#024)
Speaker: Kevin Campbell (USA)
Population Pharmacokinetic Modeling and Simulation to Assess the Impact of an 8 Week Maintenance Dosing Regimen for Intramuscular Testosterone Undecanoate (#025)
Speaker: Alexander Pastuszak (USA)
Hypogonadal Men Treated with an Oral Testosterone Undecanoate had Persistent Improved Sexual Symptom Scores Over One Year (#026)
Speaker: Christina Wang (USA)
Comparison of Outcomes for Hypogonadal Men Treated with Intramuscular Testosterone Cypionate Versus Subcutaneous Testosterone Enanthate (#027)
Speaker: Edward Choi (USA)
Assessment of Testosterone Levels in Men Receiving Immunotherapy for Malignant Melanoma (#028)
Speaker: Madeline Peters (USA)
Improved Maintenance on Index Therapy and Decreased Risk of Hypertension Among Men Treated with Injections of Long-Acting Testosterone Undecanoate Compared with Short-Acting Testosterone Cypionate (#029)
Speaker: Abraham Morgentaler (USA)
Trends in Testosterone Therapy (#030)
Speaker: Jesse Ory (USA)
Effect of Oral Testosterone Undecanoate on Gonadotropin Concentrations, Stratified by Age (#031)
Speaker: Parviz Kavoussi (USA)
Classification of Hypogonadism Among Men with a Solitary Testis (#032)
Speaker: Jesse Ory (USA)
Trends in Testosterone Prescription Modalities Amongst Medical Specialties: A 5-year CMS Data Analysis (2013-2017) (#033)
Speaker: Michael Callegari (USA)
Post-market Safety and Efficacy Profile of Subcutaneous Testosterone Enanthate-autoinjector (#034)
Speaker: Perry Xu (USA)
TLANDO, Oral Testosterone Replacement Therapy without Dose Titration Requirement (#035)
Speaker: Anthony DelConte (USA)
The Potential Effect of Racial Variations on Normalization of Testosterone Levels in Hypogonadal Men Receiving Testosterone Pellets (#036)
Speaker: Melissa Wong (USA)
Is Oral Testosterone a Potential Treatment for COVID-19 in Men? (#037)
Speaker: Benjamin Bruno (USA)
Barriers to Receiving Testosterone Replacement Therapy in the Community during COVID-19 Pandemic (#038)
Speaker: Victoria Troesch (USA)
Testosterone Replacement Therapy and Prostate Cancer (#039)
Speaker: Michael Polchert (USA)
Developing an In-Office Tool to Identify Patients with a Rare and Debilitating Orgasmic Illness (#040)
Speaker: Caleb Natale (USA)
Novel Use of a Shockwave Device for Energy Flux Density Threshold Testing of the Distal Ventral Erect Penile Shaft as a Marker of Penile Dysesthesia/Hypersensitivity Associated with Premature Ejaculation (#041)
Speaker: Maria Uloko (USA)
Successful treatment strategies in two patients with Postorgasmic illness syndrome (POIS) (#042)
Speaker: Joanna Orzel (USA)
Tuesday, November 10, 2020
Tuesday, November 10, 2020
07:00 p.m. - 09:00 p.m.
Abstract Session 3 - Peyronie's Disease
Moderators: Tung-Chin (Mike) Hsieh, MD & Laurence Levine, MD
Electronic Nicotine Delivery Systems Elevate Oxidative Stress and Accelerate Fibrosis Within the Mouse Corpora Cavernosa. (#043)
Speaker: Sabine Nguyen (USA)
Neurovascular Bundle Mobilization is Associated with Worse Long-term Erectile Function after Incision and Grafting for Peyronie's Disease (#044)
Speaker: Christopher Loftus (USA)
Penile Extra-Tunical Graft For Reconstruction Of Peyronie's Disease Concavity Deformities (#045)
Speaker: Maia VanDyke (USA)
What is a Good-Looking Penis? A Genital Appraisal for Peyronie's Disease (#046)
Speaker: Stephanie Stillings (USA)
Penile Ring Block Using Long-Acting Liposomal Bupivicaine to Minimize Postoperative Narcotic Use After Surgery for Peyronie's Disease: A Pilot Study (#047)
Speaker: Cameron Britton (USA)
Erectile Dysfunction and Penile Prosthesis Implantation After Partial Plaque Excision and Grafting for Peyronie's Disease (#048)
Speaker: Petar Bajic, MD (USA)
Does the Clasification of Peyronie's Disease with Doppler US Affect Surgical Intervention Pursued by the Patient? (#049)
Speaker: Giovanni Gonzalez Albo (USA)
Canadian Provider Perspectives on Collagenase Clostridium Histolyticum for the Treatment of Peyronie's Disease and the Impact of its Discontinuation (#050)
Speaker: Kunal Jain (Canada)
A Prospective Study on the Association Between Plaque Calcification and Penile Curvature in Men with Peyronie's Disease (#051)
Speaker: Madhumita Parmar (USA)
Can Penile Doppler Ultrasound Change Management in Men with Peyronie's Disease ? (#052)
Speaker: Iakov Efimenko (USA)
Assessment of The Reliability of YouTube Videos Related to Peyronie's Disease as A Patient Education Resource (#053)
Speaker: Christopher Warren (USA)
Factors Influencing Patient Consideration of Surgery at Initial Consultation for Peyronie's Disease (#054)
Speaker: Elizabeth Bearrick (USA)
Minimally Invasive vs. Degloving Plication for Correction of Congenital Penile Curvature (#055)
Speaker: Samuel Kusin (USA)
Racial Variation in Severity and Choice of Treatment Modality in Peyronie's Disease (#056)
Speaker: Hoang Minh Tue Nguyen (USA)
Cost of Intralesional Collagenase Clostridium Histiolyticum Therapy Versus Surgery for the Management of Peyronie's Disease: A Claims-Based Analysis (2009-2018) (#057)
Speaker: Timothy Quinn (USA)
Mechanical Characterization of Fibrotic and Mineralized Tissue in Peyronie's Disease (#058)
Speaker: Lynda Brady (USA)
What Vascular Insufficiencies are Observed in Patients with Erectile Dysfunction and Peyronie's Disease? (#059)
Speaker: Ayman Soubra (USA)
Regional Differences in The Incidence and Prevalence of Peyronie's Disease in The United States - Results from a Claims and Encounters Database (#060)
Speaker: Odinachi Moghalu (USA)
Comparative Analysis of Gut Microbiome Composition between Men with Peyronie's Disease and a Matched Cohort: Is there a difference? (#061)
Speaker: Mohamad Osman (USA)
Comparison of Patient Demographics and Surgical Trends in Peyronie's Disease: A NSQIP Study (#062)
Speaker: Karishma Gupta (USA)
07:00 p.m. - 09:00 p.m.
Abstract Session 4 - Miscellaneous
Moderators: Lawrence Jenkins, MD, MBA & Marc Rogers, MD
Orgasmic Dysfunction after Robot-assisted Radical Prostatectomy: A Survey of Patient and Partner Outcomes (#063)
Speaker: Farouk El-Khatib (USA)
Non-contrast MRI Visualization of Penile Vessels Anatomy (#064)
Speaker: Ilya Pyatnitskiy (Russia)
Perspectives of Non-contrast MRI for Penile Veins Visualization (#065)
Speaker: Ilya Pyatnitskiy (Russia)
Revactin®, a Nutraceutical Combination, Activates the iNOS/cGMP Pathway in Human Corporal Smooth Muscle Cells (#066)
Speaker: Leslie Graciano (USA)
Dynamic MRI of the Male Pelvic Floor (#067)
Speaker: Ilya Pyatnitskiy (Russia)
Use of RestoreX Penile Traction Therapy for Treatment of Penile Length Loss in Diabetic Men (#068)
Speaker: David Yang (USA)
Satisfaction Rates of Inflatable Penile Prostheses in Men who have Sex with Men (#069)
Speaker: Justin La (USA)
Decreasing Physician Reimbursement in the Context of Increasing Hospital Reimbursement and Device Cost for Male Sling and Penile Prosthesis: 2007 to 2020 (#070)
Speaker: Victoria Edmonds (USA)
Decreasing Medicare Reimbursement for Men's Health Procedures: 2002-2020 (#071)
Speaker: Victoria Edmonds (USA)
Mentorship not Medical School Promotes Pursuit of Sexual Medicine Fellowship (#072)
Speaker: Niki Parikh (USA)
Evaluation of Hip Pathology in Men Presenting with Chronic Scrotal Content Pain (#073)
Speaker: Emily Solsrud (USA)
Health Literacy is Not Associated with Complication Rates after Urologic Prosthetic Surgery (#074)
Speaker: Benjamin Dropkin (USA)
(Mis)information in the Vasectomy Decision-Making Process: A Quality Appraisal of Vasectomy-Related Information on YouTube (#075)
Speaker: Jacob Lang (USA)
Post-SSRI Sexual Dysfunction (PSSD): Ten Year Retrospective Chart Review (#076)
Speaker: Ahad Waraich (USA)
Spermatic Cord Block Series as a Minimally Invasive Treatment For Chronic Scrotal Content Pain (#077)
Speaker: Daniel Simon (USA)
Patient Satisfaction with Telemedicine Appointments in an Academic Andrology-focused Urology Practice during the COVID-19 Pandemic (#078)
Speaker: Benjamin Shiff (Canada)
A Random Forest Classifier for the Prediction of Testosterone Deficiency in the Community Setting (#079)
Speaker: Osmar Luiz Carvalho (Brazil)
Efficacy of Ilioinguinal and/or Iliohypogastric Nerve Blocks for the Treatment of Orchialgia (#080)
Speaker: Nick Jensen (USA)
Using Portable Ultrasound Guidance and Direct Incision as Reliable Technique for Retrieval of Retained Hypodermic Needle: A Rare Complication of Intracavernosal Injection (#081)
Speaker: Yurong Mai (USA)
Evaluation of Postoperative Outcomes in Chronic Scrotal Content Pain: Early Results from a Prospective Multicenter Series (#082)
Speaker: Cameron Britton (USA)
Wednesday, November 11, 2020
Wednesday, November 11, 2020
07:00 p.m. - 09:00 p.m.
Abstract Session 5 - Male Medical
Moderators: Seth Cohen, MD, MPH & Kelli Gross, MD
Intracavernosal Injections of Stromal Derived Factor-1 (SDF1) Prevents Erectile Dysfunction in Nerve Injury Model by Increasing Stem Cell Upregulation in the Penis (#083)
Speaker: James Liu (USA)
Sonic Hedgehog Signaling in Corporal Cavernosal Cells from Prostatectomy, Diabetic, Hypertension and Peyronie's Patients with ED (#084)
Speaker: Sarah Martin (USA)
Expression of MicroRNAs (miR-15b, miR-16, miR-138, miR-221 and miR-222) as Biomarkers of Endothelial Corpus Cavernosum Dysfunction in an Alcoholic Diabetic Murine Model (#085)
Moderator: Ricardo Tiraboschi (Brazil)
Penile Traction Therapy Improves Penile Length and Increases Cavernosal Endothelial Nitric Oxide Synthase Expression in a Rat Model of Bilateral Cavernous Nerve Crush Injury (#086)
Speaker: Brian Dick (USA)
Study on the prevalence of Sleep Disorders in patients with Erectile Dysfunction (#087)
Speaker: Sujith Jose (India)
Efficacy of RestoreX Penile Traction Therapy in Improving Penile Length and Erectile Function Post Prostatectomy (#088)
Speaker: David Yang (USA)
Mirabegron for Erectile Dysfunction (#089)
Speaker: Serkan Karakus (USA)
Organic Diet and Intermittent Fasting are Associated with Improved Erectile Function (#090)
Speaker: Linda Huynh (USA)
Novel Indices for the Evaluation of Obesity in patients with Erectile Dysfunction (#091)
Speaker: Sujith Jose (India)
Proposed Mechanisms of Erectile Function Improvement with Low Intensity Shockwave Therapy: Vascular and Erectile Tissue Health Changes Pre- and Post-Treatment (#092)
Speaker: Jessica Yih (USA)
Tracking use of Non-prescription and Herbal Supplements by Men with ED (#093)
Speaker: Franklin Burg (USA)
Platelet-Rich Plasma and Stem Cell Therapy for Erectile Dysfunction: Characterization of Market Forces in a Major Metropolitan Area (#094)
Speaker: Robert Shahinyan (USA)
Utility of Ceramide Testing in Men with Erectile Dysfunction (#095)
Speaker: C. Scott Collins, MD (USA)
Recent Institutional Experience with Penile Duplex Doppler Ultrasound in Patients with Erectile Dysfunction (#096)
Speaker: Joseph Kim (USA)
Bidirectional Referral for Erectile Dysfunction Risk Stratification in Young Men (#097)
Speaker: Alvaro Santamaria (USA)
Trends in Marketing, Pricing, and Deployment of Shock Wave Therapy for Erectile Dysfunction in a Major Metropolitan City (#098)
Speaker: James M. Weinberger (USA)
Erectile Dysfunction and Body-related Emotions in Morbid Obese Men before Undergoing Bariatric Surgery: EFIBAR Study (#099)
Speaker: Laura López-Sánchez (Spain)
Piezo 1 Mechanosensor is Impaired in the Pudendal Artery and Corpus Cavernosum of Spontaneously Hypertensive Rats (#100)
Speaker: Fernanda Priviero (USA)
Sexual Function Meta-Analysis of Treatment with Prostatic Urethral Lift Compared to Medical Therapy (#101)
Speaker: Daniel Rukstalis (USA)
Restorative Therapies for Erectile Dysfunction: Comparing Trends in Patient Interest Against Guideline-Backed Therapies (#102)
Speaker: Shangyang Christopher Yang (USA)
Diabetes and Erectile Dysfunction: Does Evidence based Testing Inform Us? (#103)
Speaker: Amanda Myers (USA)
Platelet-rich plasma Injections for Erectile Dysfunction and Peyronie's Disease: A Systematic Review of Evidence. (#104)
Speaker: Nawar Touma (Canada)
07:00 p.m. - 09:00 p.m.
Abstract Session 6 - BPH and Reconstruction
Moderators: Ryan Terlecki, MD & Charles Welliver, MD
Climacturia and Timing of Incontinence Recovery Post-radical Prostatectomy (#105)
Speaker: Edward Choi (USA)
Maximization of Membranous Urethral Length During Robot-assisted Radical Prostatectomy Increases Climacturia Recovery (#106)
Speaker: Farouk El-Khatib (USA)
Sexual Functional Outcomes of Primary Focal Versus Whole Gland Cryotherapy of the Prostate: Propensity Score Comparative Matching (#107)
Speaker: Wade Muncey (USA)
Erectile Function Following Prostate Artery Embolization in Patients with Larger Prostate Glands: A Large Single Center Experience (#108)
Speaker: Jessica Kumar (United States)
TSPO Ligand FGIN-1-27 Controls Priapism in Sickle Cell Mice via Endogenous Testosterone Production (#109)
Speaker: Serkan Karakus (USA)
Foreplay Incontinence, Climacturia, and Stress Incontinence Treated with Mini-Jupette Slings (#110)
Speaker: Jeff Brady (USA)
First-time Transcorporal vs Standard Artificial Urinary Sphincter Placement in Patients with Prior Tadiation for Prostate Cancer: A Comparison of Outcomes (#111)
Speaker: David Miller (USA)
Male Stress Urinary Incontinence is Underreported in One-Third of Cases: A Comparison of Patient History and Physical Exam Findings (#112)
Speaker: Avery Wolfe (USA)
ProACT: A Minimally Invasive Alternative for the Treatment of Post-Prostatectomy Incontinence (#113)
Speaker: Ash Bowen (USA)
Climacturia After Robot Assisted Radical Prostatectomy: Does Pre-operative Erectile Dysfunction Affect Who Recovers? (#114)
Speaker: Farouk El-Khatib (USA)
Changing Trends in Management following Artificial Urinary Sphincter Surgery for Male Stress Urinary Incontinence: An Analysis of the National Surgical Quality Improvement Program Database (#115)
Speaker: Thomas Max Shelton (USA)
Comparison of Nitrous Oxide Sedation versus Oral Sedation in Patients Undergoing Rezūm Prostate Ablation: A Feasibility Study (#116)
Speaker: Ajay Gopalakrishna (USA)
Evaluation of Safety and Outcomes in Urolift® with an Inflatable Penile Prosthesis (#117)
Speaker: Nir Tomer (USA)
Evaluation of Long Term Complication Rates of Primary Transcorporal Artificial Urinary Sphincter Cuff Placement (#118)
Speaker: Nicole Dodge (USA)
Prostatic Urethral Lift in Patients with Obstructive Median Lobes: A Single Surgeon Experience at an Academic Center (#119)
Speaker: Matthew Rabinowitz (USA)
The Effect of Sexual Dysfunction on Health-Related Quality of Life in Men Following Traumatic Pelvic Fractures (#120)
Speaker: Alice Wang (USA)
Contemporary Trends in Ischemic Priapism: A Multi-Institutional Study (#121)
Speaker: Petar Bajic, MD (USA)
Regimented Phosphodiesterase Type 5 Inhibitor Use Reduces Emergency Department Visits for Recurrent Ischemic Priapism (#122)
Speaker: Laurence Hou (USA)
Predictive Factors to Determine Treatment Course of Patients with First-time Priapism (#123)
Speaker: William Du Comb (USA)
Sex, Drugs, and Ischemic Priapism: Insights into the Culture Surrounding Recreational use of Intracavernosal Injectables in an Urban Population (#124)
Speaker: John M. Masterson (USA)
Unilateral Corpora Cavernosum Partial Thrombosis: A Challenging Presentation and Management (#125)
Speaker: Omer Raheem, MD (USA)
Thursday, November 12, 2020
Thursday, November 12, 2020
07:00 p.m. - 09:00 p.m.
Abstract Session 7 - Female Sexual Dysfunction and Transgender Medicine
Moderators: Sue W. Goldstein, BA, CCRC, AASECT-CSE, IF & Sharon Parish, MD, IF, NCMP
A Novel Collaborative Protocol for Successful Management of Genito-Pelvic Dysesthesia Mediated by Radiculopathy of Sacral Spinal Nerve Roots Within the Cauda Equina: Four Year Experience (#126)
Speaker: Choll Kim, MD, PhD (USA)
Pathology Staining for Mast Cells and Nerves on Vestibular Tissue from Patients Suspected of Having Neuroproliferative Vestibulodynia (NPV): A Case Series (#127)
Speaker: Maria Uloko (USA)
STOMP: Sexual function Trial of Overactive bladder: Medication versus PTNS (#128)
Speaker: Allison Polland (USA)
Neuroproliferative Vestibulodynia as a Cause of Persistent Genital Arousal Disorder: A First-Ever Case Series (#129)
Speaker: Maria Uloko (USA)
Understanding Psychosocial and Sexual Health Concerns among Women with Bladder Cancer Undergoing Radical Cystectomy (#130)
Speaker: Natasha Gupta (USA)
Sexual Health Influences in Women: A Cross-Sectional Survey (#131)
Speaker: Justin Dubin (USA)
Female Perceptions of Erectile Dysfunction and the Role of Male Blame on Female Sexual Health: A Cross-Sectional Survey (#132)
Speaker: Justin Dubin (USA)
The Vulvar Exam: An Essential Tool for the Urologist (#133)
Speaker: Jenna Dickman (USA)
Lumbo-Sacral Low Intensity Shockwave Therapy for Persistent Genital Arousal Disorder/Genito-Pelvic Dysesthesia Using the UroGold 100 MTS (#134)
Speaker: Jessica Yih (USA)
Association of Sexual Function with BMI and Cardiorespiratory Fitness in Morbid Obese Women awaiting Bariatric Surgery: EMOVAR study (#135)
Speaker: Elena Martínez-Rosales (Spain)
Sexual Dysfunction Changes in Morbid Obese Women Undergoing Bariatric Surgery after an Exercise Intervention: Emovar Study (#136)
Speaker: Alba Hernández-Martínez (Spain)
Penile and Scrotal Skin Measurements to Predict Final Vaginal Depth in Penile Inversion Vaginoplasty: A Guide for Pre-Operative Patient Counseling and Surgical Planning (#137)
Speaker: Maurice Garcia, MD, MAS (USA)
Perioperative Morbidity of Gender Affirming Surgery: Analysis of the National Surgical Quality Improvement Program (NSQIP) Database (#138)
Speaker: Cooper Benson (US)
Comparison of Permanent Hair-Removal Procedures before Gender-affirming Vaginoplasty: Why We Should Consider Laser Hair Removal as a First-line Treatment for Properly Selected Patients (#139)
Speaker: Nance Yuan (USA)
Self-Reported Sexual Orientation and Attraction in a Cohort of Binary- and Non-Binary Transmasculine Patients Seeking Gender Affirming Surgery (#140)
Speaker: Elizabeth Boskey (USA)
Bi-institutional Review of Anastomotic Stricture Repairs in Transgender Men Post-phalloplasty (#141)
Speaker: Jessica Schardein (USA)
Use of the Deep Inferior Epigastric Vessels for Arterial-venous Anastomosis with Free-flap Phallo-urethroplasty: Technique, Key points, and Lessons Learned (#142)
Speaker: Nance Yuan (USA)
Characterizing Transgender Individuals Undergoing Bilateral Simple Orchiectomy Without Concomitant Vaginoplasty or Vulvoplasty (#143)
Speaker: Craig Sineath (USA)
Newer Surgical and Technological Developments in Penile Prosthesis Devises: Systematic Analysis (#144)
Speaker: Omer Raheem, MD (USA)
Evaluation of Educational Intervention in Addressing Culturally-Sensitive Care for the Transfemme Patient (#145)
Speaker: Pombie Silverman (USA)
07:00 p.m. - 09:00 p.m.
Abstract Session 8 - Male Surgical
Moderators: Martin Gross, MD & Timothy J. Tausch, MD
Do Antifungals and Local Anesthetic Affect the Efficacy of Antibiotic Dipping Solution? A Detailed Investigation of the Practice Across Multiple Species (#146)
Speaker: Kirtishri Mishra (USA)
An Evaluation of Penile Implant Biofilms using Next Generation DNA Sequencing: Is there a difference in Diabetic Patients? (#147)
Speaker: Erica Mann (USA)
Infection Retardant Coatings Decrease Bacteria Cultured During Penile Prosthesis Revision Washout. Subsequent Device Infection Is Reduced But, Upon the Rare Occurrence, the Bacteria Were Unexpectedly Different (#148)
Speaker: Gerard Henry, MD (USA)
Defining the Risk of Opioid Dependence after Inflatable Penile Prosthesis in the Era of Multi-Modal Analgesia (#149)
Speaker: Avery Braun (USA)
Evaluation and Treatment of Complications of Penuma Penile Implant (#150)
Speaker: Akash Kapadia (USA)
Comparative Analysis of Long-term Outcomes of Two-piece versus Three-piece Inflatable Penile Prosthesis (#151)
Speaker: Joseph Kim (USA)
Inflatable Penile Prosthesis Infections: Are We Covered? (#152)
Speaker: Lindsay White (USA)
Is Immediate Preoperative Blood Glucose or Hemoglobin a1c a Risk Factor for Infection Following Penile Prosthesis Placement? A Systematic Review of Literature (#153)
Speaker: Linda Huynh (USA)
Drain Duration Following IPP Implantation: An Infection Rate and Opiate use Analysis (#154)
Speaker: Michael Tonzi (USA)
Factors Influencing Penile Prosthesis Size in Post-Prostate Cancer Erectile Dysfunction (#155)
Speaker: Jack Campbell (USA)
Does Knowing Pre-operative Penile Length Influence Patient Satisfaction Post Penile Prosthesis Surgery (#156)
Speaker: Travis Green (USA)
Trans-facial, Submuscular Reservoir Placement: A Safe and Accurate Technique for Deploying an Ectopic Reservoir in Patients who have Undergone Prior Pelvic Surgery or Radiation Therapy (#157)
Speaker: Bruce Kava (USA)
Penile Length Shortening Following Robot-assisted Radical Prostatectomy: Impacts on Erections and Sexual Bother (#158)
Speaker: Farouk El-Khatib (USA)
Comparing Patient Satisfaction in Penile Prosthesis Surgery after Radical Prostatectomy Versus the General Population (#159)
Speaker: Chris Kannady (USA)
Three-Piece Inflatable Penile Prosthesis Revision Surgery Leads to Increased Implant Size Independent of Revision Indication (#160)
Speaker: Matthew Pollard (USA)
Auto-inflation, Pain, and Partner Findings from the EROS (Erectile Restoration Outcomes Study) Registry (#161)
Speaker: Alex Ferguson (USA)
Explantation of High Submuscular Reservoirs: Safety and Practical Considerations (#162)
Speaker: Mehraban Kavoussi (USA)
Evaluation of Safety and Outcomes in Rezum® with an Inflatable Penile Prosthesis (#163)
Speaker: Nir Tomer (USA)
CT Cavernosography: a Patient-Centered Approach to Understanding Functional Penile Abnormalities (#164)
Speaker: Diana Aponte-Colon (USA)
Pre-operative Imaging for Revision Penile Prosthesis Surgery: When Exam Alone is not Enough (#165)
Speaker: Kevin Parikh (USA)
Saturday, November 14, 2020
Saturday, November 14, 2020
07:45 p.m. - 08:30 p.m.
Abstract Awards and Residents Arena
Moderators: Alan W. Shindel, MD & Faysal Yafi, MD, FRCSC
First-time Transcorporal vs Standard Artificial Urinary Sphincter Placement in Patients with Prior Tadiation for Prostate Cancer: A Comparison of Outcomes (#111)
Speaker: David Miller (USA)
Erectile Function Following Prostate Artery Embolization in Patients with Larger Prostate Glands: A Large Single Center Experience (#108)
Speaker: Jessica Kumar (United States)
Study on the prevalence of Sleep Disorders in patients with Erectile Dysfunction (#087)
Speaker: Sujith Jose (India)
Drain Duration Following IPP Implantation: An Infection Rate and Opiate use Analysis (#154)
Speaker: Michael Tonzi (USA)
Factors Influencing Penile Prosthesis Size in Post-Prostate Cancer Erectile Dysfunction (#155)
Speaker: Jack Campbell (USA)
Penile Extra-Tunical Graft For Reconstruction Of Peyronie's Disease Concavity Deformities (#045)
Speaker: Maia VanDyke (USA)
Neurovascular Bundle Mobilization is Associated with Worse Long-term Erectile Function after Incision and Grafting for Peyronie's Disease (#044)
Speaker: Christopher Loftus (USA)
Satisfaction Rates of Inflatable Penile Prostheses in Men who have Sex with Men (#069)
Speaker: Justin La (USA)
Does Knowing Pre-operative Penile Length Influence Patient Satisfaction Post Penile Prosthesis Surgery (#156)
Speaker: Travis Green (USA)

Our Services


Established in 1994, our objective has been to promote, encourage, and support the highest standards of practice, research, education, and ethics in the study of the anatomy, physiology, pathophysiology, diagnosis, and treatment...

~ Read More

Contact Us

SMSNA Executive Office
c/o Status Plus
  +1 (952) 683 1917
 +1 (952) 314 8212

  14305 Southcross Dr
Suite 100
Burnsville, MN 55306